S Kanamori Selected Research

S 1090

5/2001	[Reproductive and developmental toxicity studies of S-1090, cefmatilen hydrochloride hydrate (2)--A study on oral administration during the period of organogenesis in rats].
5/2001	[Reproductive and developmental toxicity studies of S-1090, cefmatilen hydrochloride hydrate (1)--A study on oral administration prior to and in the early stages of pregnancy in rats].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Kanamori Research Topics

Disease

4	Neoplasms (Cancer) 02/2001 - 05/2000
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 03/2002 - 05/2000
2	Body Weight (Weight, Body) 05/2001 - 05/2001
2	Hyperthermia 01/2001 - 06/2000
1	Fetal Weight 05/2001
1	Esophageal Neoplasms (Esophageal Cancer) 02/2001
1	Esophageal Squamous Cell Carcinoma 02/2001
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2001
1	Margins of Excision 11/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2000
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2000
1	Hemangioma (Angioma) 05/2000
1	Infections 03/2000

Drug/Important Bio-Agent (IBA)

2	S 1090IBA 05/2001 - 05/2001
2	Cisplatin (Platino)FDA LinkGeneric 02/2001 - 06/2000
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2001 - 05/2000
1	GastrinsIBA 03/2002
1	KNK 437IBA 01/2001
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2001
1	Cytochalasin BIBA 06/2000
1	mahuang-tangIBA 06/2000
1	Tirapazamine (SR 4233)IBA 06/2000
1	SuspensionsIBA 06/2000
1	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 06/2000
1	Bromodeoxyuridine (BrdU)IBA 06/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2000
1	AntigensIBA 03/2000

Therapy/Procedure

2	Radiotherapy 11/2000 - 06/2000
1	Neoadjuvant Therapy 02/2001
1	Pancreatectomy 11/2000
1	Drug Therapy (Chemotherapy) 06/2000
1	Therapeutics 05/2000
1	Ligation 05/2000